Exact Mass: 1085.4534914

Exact Mass Matches: 1085.4534914

Found 13 metabolites which its exact mass value is equals to given mass value 1085.4534914, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

13Z,16Z-docosadienoyl-CoA

{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-({[({[(3R)-3-{[2-({2-[(13Z,16Z)-docosa-13,16-dienoylsulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-3-hydroxy-2,2-dimethylpropoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}methyl)-4-hydroxyoxolan-3-yl]oxy}phosphonic acid

C43H74N7O17P3S (1085.4074544)

13Z,16Z-docosadienoyl-CoA is classified as a member of the Very long-chain fatty acyl CoAs. Very long-chain fatty acyl CoAs are acyl CoAs where the group acylated to the coenzyme A moiety is a very long aliphatic chain of 22 carbon atoms or more. 13Z,16Z-docosadienoyl-CoA is considered to be practically insoluble (in water) and acidic. 13Z,16Z-docosadienoyl-CoA is a fatty ester lipid molecule

C57H67NO20

C57H67NO20 (1085.4256222)

13Z,16Z-docosadienoyl-CoA

(13Z,16Z)-Docosadi-13,16-enoyl-CoA

C43H74N7O17P3S (1085.4074544)

CoA 22:2

13Z,16Z-docosadienoyl-CoA

C43H74N7O17P3S (1085.4074544)

Docosanoyl-CoA

C43H74N7O17P3S-4 (1085.4074544)

(2E,13Z)-docosadienoyl-CoA

C43H74N7O17P3S (1085.4074544)

An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,13Z)-docosadienoic acid.

An acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of behenoyl-CoA; major species at pH 7.3.

Docosenoyl-CoA

C43H74N7O17P3S (1085.4074544)

n-(6,19-dihydroxy-20-{[hydroxy(quinolin-3-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triaconta-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

n-(6,19-dihydroxy-20-{[hydroxy(quinolin-3-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28,29-dithia-2,5,12,15,18,25-hexaazabicyclo[12.12.4]triaconta-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

C51H63N11O12S2 (1085.4098878)

(2r,3r,4e,6r)-6-[(1r,3as,3bs,5s,7s,9as,11ar)-5-{[(2r,3r,4s,5r,6r)-4-{[(2s,3r,4s,5r)-3-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9a,11a-dimethyl-7-(sulfooxy)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethyl-n-(2-sulfoethyl)hept-4-enimidic acid

(2r,3r,4e,6r)-6-[(1r,3as,3bs,5s,7s,9as,11ar)-5-{[(2r,3r,4s,5r,6r)-4-{[(2s,3r,4s,5r)-3-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9a,11a-dimethyl-7-(sulfooxy)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethyl-n-(2-sulfoethyl)hept-4-enimidic acid

C48H79NO22S2 (1085.4534914)